Compare Organon & Co. Common Stock (OGN) vs First Trust Cloud Computing ETF (SKYY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon & Co. Common Stock vs First Trust Cloud Computing ETF — how do they compare? Organon & Co. Common Stock trades at $13.58 (market cap $3.62B), while First Trust Cloud Computing ETF trades at $163.94 (market cap $3.57B). The key difference: Organon & Co. Common Stock and First Trust Cloud Computing ETF are close in size by market cap, and Organon & Co. Common Stock pays a 0.58% dividend while First Trust Cloud Computing ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Organon & Co. Common Stock for 0 Days and First Trust Cloud Computing ETF for 84 Days on average.
| OGN | SKYY | |
|---|---|---|
Market Cap | $3.62B | $3.57B |
Volume | 2,892,999 | 236,993 |
Sector | Health | — |
52-Week High | $13.81 | $174.89 |
52-Week Low | $5.70 | $104.16 |
Typical Hold Time | 0 Days | 84 Days |
Enterprise Value | $11.04B | — |
Dividend Yield | 0.58% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
SKYY, the First Trust Cloud Computing ETF, trades at $171.52, down 0.57% today but near its 52-week high. Technical indicators show a bullish trend with strong moving average support, though RSI suggests mild overbought conditions. The ETF provides diversified exposure to the cloud computing sector, benefiting from AI adoption and digital transformation trends. Recent news highlights institutional adjustments and positive coverage on cloud infrastructure growth.
The outlook for SKYY is positive, driven by secular trends in cloud computing and AI. Investment opportunities include sector growth and diversification benefits, while risks involve market volatility and sector-specific competition. The ETF's performance hinges on continued tech infrastructure spending and macroeconomic conditions affecting tech stocks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Organon & Co. Common Stock
Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →About First Trust Cloud Computing ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is designed to track the performance of companies involved in the cloud computing industry.
Read more on SKYY →
